TD Cowen raised the firm’s price target on Cardinal Health to $90 from $88 and keeps a Market Perform rating on the shares. The firm said the focus remains on the Medical Improvement Plan and seeing the company achieve continued inflation mitigation in FY24.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CAH:
- Cardinal Health (NYSE:CAH) Stock Down Despite Positive Q4 Results
- Cardinal Health raisesFY24 EPS view to $6.50-$6.75 from $6.45-$6.70
- Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2023 at High End of Investor Day Guidance
- Cardinal Health reports Q4 EPS $1.55, consensus $1.49
- Notable companies reporting before tomorrow’s open